<DOC>
	<DOCNO>NCT01263535</DOCNO>
	<brief_summary>This clinical trial design investigate performance SENSIMED Triggerfish® 24-hour continuous IOP fluctuation monitoring , define number valid recording interval 24-hour period . The investigation recruit male female patient older 18 year diagnose glaucoma treat tafluprost eye . 20 subject enrol study . Patients consider enrolled study upon signature inform consent . A screening visit one 24-hour IOP fluctuation monitoring session 36-hour hospitalisation , plan patient .</brief_summary>
	<brief_title>Use Ocular Telemetry Sensor Tafluprost Treated Patients</brief_title>
	<detailed_description />
	<criteria>Older 18 year . Untreated IOP ≥22 mmHg eye . Documented , typical glaucomatous visual field ( VF ) loss ( nasal step , arcuate , paracentral Seidel 's scotoma ) determine automate static threshold perimetry ( Octopus 100 ) , glaucomatous optic nerve head cupping ( neural rim notch saucerization ) eye . Patients tafluprost treatment since least 4 week eyes . Patients accept sign informed consent approve Ethics Committee . Patients able understand nature research Patients tutorship Corneal abnormality eye Subjects contraindication wear contact lenses History ocular surgery within last 3 month Known hypersensitivity tafluprost excipients Fullframe metal glass monitoring SENSIMED Triggerfish® Pregnancy lactation Simultaneous participation clinical research Patients evidence ocular infection inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>